Amgen Inc v. Annora Pharma Private Limited

Court

District Court, D. Delaware (D. Del.)
Official Court Website →

Assigned judge

Colm F. Connolly · 1,962 cases in index

Docket number

1:20-cv-00122

Cause

35:1 Patent Infringement
35 U.S.C. § 1

Nature of suit

835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application.

Jurisdiction

Federal Question

Jury demand

None

Date filed

01/24/2020

Date terminated

02/09/2022

1,113 Patent - ANDA cases in this court are indexed here.

Parties

• plaintiff · Amgen Inc Pharmaceuticals & Biotechnology · 229 cases
• defendant · Annora Pharma Private Limited · 15 cases

Part of a Larger Litigation Pattern

This is one of 16 Patent - ANDA cases in our index naming ANNORA PHARMA PRIVATE LIMITED — a possible mass-tort or coordinated-litigation cluster.

• Mirum Pharmaceuticals, Inc v. Annora Pharma Private Limited
  District Court, D. DelawareFiled 12/19/2025
• Azurity Pharmaceuticals, Inc v. Annora Pharma Private Limited
  District Court, D. DelawareFiled 09/12/2025
• Pfizer Inc v. Annora Pharma Private Limited
  District Court, D. DelawareFiled 06/09/2023
• Hikma Pharmaceuticals USA Inc v. Annora Pharma Private Limited
  District Court, D. DelawareFiled 03/02/2023
• Catalyst Pharmaceuticals, Inc v. Annora Pharma Private Limited
  District Court, D. New JerseyFiled 03/01/2023
• Pierre Fabre Medicament Sas v. Annora Pharma Private Limited
  District Court, D. DelawareFiled 11/02/2022

About Patent - ANDA Lawsuits

ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

Frequently Asked Questions

What is Amgen Inc v. Annora Pharma Private Limited?

Amgen Inc v. Annora Pharma Private Limited is a federal patent - anda lawsuit filed on 01/24/2020 in the District Court, D. Delaware. The case was terminated on 02/09/2022. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What type of case is this?

It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.

What court is the case in?

The case is in the District Court, D. Delaware, docket number 1:20-cv-00122.

When was the case filed?

Amgen Inc v. Annora Pharma Private Limited was filed on 01/24/2020. It was terminated on 02/09/2022.

What law is the case brought under?

The docket lists the cause as 35 U.S.C. § 1.